Save on prescriptions with one trusted mobile app (LATHAM, NY) – Araya announces a strategic partnership with Levrx Technology Inc. to help Araya clients and members save money
Healthcare giant CVS Health closed its $70 billion deal to buy Aetna on Wednesday, ending months of review from state and federal regulators. The deal,
A recent study using Medicaid enrollee data showed that medical marijuana laws and adult-use marijuana laws were associated with lower opioid prescribing rates. A second
Officials with Gilead Sciences, Inc. plan to launch authorized generic versions of sofosbuvir 400 mg/velpatasvir 100 mg (Epclusa) and ledipasvir 90mg/sofosbuvir 400 mg (Harvoni), Gilead’s leading
Stephanie Roberts has been promoted to Director of Operations. Stephanie has been with Araya since 2013. During her time with Araya, Stephanie has performed many
Araya is supporting the DEA’s National Prescription Drug Take Back Day by ensuring many of its members are aware of the date and how to
A new lawsuit alleges pharmaceutical manufacturers knew the addictive nature of opioids but peddled them to doctors and patients anyway. Albany County wants the companies
A multistate antitrust investigation on generic drug pricing has expanded further. It now includes suits against executives at generic makers. In late October, Connecticut Attorney
